TREVI HEALTH VENTURES
Trevi Health Ventures is a private equity venture capital firm that specializes in growth equity investments. It provides healthcare-focused alternative asset management through private equity funds on a global scale. It also provides development and growth capital for private healthcare companies with emphasis on medical devices, biopharmaceuticals, and healthcare services. The company invests, directly and with its strategic partners, in special situations, traditional buy-outs and structured finance transactions. Trevi Health Ventures is a U.S.-based company that was founded in 2005 by David Robbins and Andrew Fink.
TREVI HEALTH VENTURES
Industry:
Finance Financial Services Venture Capital
Founded:
2005-01-01
Status:
Closed
Contact:
(212) 813 9201
Email Addresses:
[email protected]
Technology used in webpage:
SPF IPv6 Google Maps Microsoft Azure DNS Google Maps API Cloudflare Hosting Cloudflare DNS Google Maps For Work Network Solutions Email Hosting
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2013-03-04 | US HealthVest | Trevi Health Ventures investment in Series A - US HealthVest | 36 M USD |
| 2013-01-22 | Manhattan Labs | Trevi Health Ventures investment in Venture Round - Manhattan Labs | 3.7 M USD |
| 2009-09-15 | Paradigm Spine | Trevi Health Ventures investment in Series E - Paradigm Spine | 6.5 M USD |
| 2009-04-30 | Small Bone Innovations | Trevi Health Ventures investment in Series D - Small Bone Innovations | 108 M USD |
| 2008-07-02 | MedAvante | Trevi Health Ventures investment in Venture Round - MedAvante | 20 M USD |
| 2008-01-01 | Small Bone Innovations | Trevi Health Ventures investment in Series C - Small Bone Innovations | 36 M USD |
| 2007-03-30 | Optovue | Trevi Health Ventures investment in Series B - Optovue | 10.5 M USD |
| 2007-02-12 | Omeros | Trevi Health Ventures investment in Series E - Omeros | 63 M USD |
| 2006-03-08 | Ikonisys | Trevi Health Ventures investment in Series D - Ikonisys | 10 M USD |